Serum exosomes miR-206 and miR-549a-3p as potential biomarkers of traumatic brain injury

• Published in: Scientific Reports
• Main Authors: Yajun Yang, Yi Wang, Panpan Li, Feirong Bai, Cai Liu, Xintao Huang
• Format: Article
• Language: English
• Published: Nature Portfolio 2024-05-01
• Subjects: TBI; Biomarker; Exosomes; miR-206; miR-549a-3p
• Online Access: https://doi.org/10.1038/s41598-024-60827-8

Abstract Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. However, effective diagnostic, therapeutic and prognostic biomarkers are still lacking. Our research group previously revealed through high-throughput sequencing that the serum exosomes miR-133a-3p, miR-206, and miR-549a-3p differ significantly in severe TBI (sTBI), mild or moderate TBI (mTBI), and control groups. However, convincing experimental evidence is lacking. To solve this problem, we used qPCR in this study to further verify the expression levels of serum exosomes miR-133a-3p, miR-206 and miR-549a-3p in TBI patients. The results showed that the serum exosomes miR-206 and miR-549a-3p showed good predictive value as biomarkers of TBI. In addition, in order to further verify whether serum exosomes miR-206 and miR-549a-3p can be used as potential biomarkers in patients with TBI and to understand the mechanism of their possible effects, we further determined the contents of SOD, BDNF, VEGF, VEGI, NSE and S100β in the serum of TBI patients. The results showed that, serum exosomes miR-206 and miR-549a-3p showed good correlation with BDNF, NSE and S100β. In conclusion, serum exosomes miR-206 and miR-549a-3p have the potential to serve as potential biomarkers in patients with TBI.